CenterBook Partners LP Boosts Stock Holdings in Sotera Health Company $SHC

CenterBook Partners LP increased its position in shares of Sotera Health Company (NASDAQ:SHC) by 94.1% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 151,529 shares of the company’s stock after buying an additional 73,473 shares during the quarter. CenterBook Partners LP’s holdings in Sotera Health were worth $2,673,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. JPMorgan Chase & Co. raised its holdings in Sotera Health by 20.3% in the 4th quarter. JPMorgan Chase & Co. now owns 285,691 shares of the company’s stock worth $5,040,000 after purchasing an additional 48,115 shares during the period. Syon Capital LLC purchased a new position in shares of Sotera Health during the 4th quarter valued at approximately $246,000. Los Angeles Capital Management LLC acquired a new stake in Sotera Health in the 4th quarter valued at $90,000. Two Seas Capital LP grew its stake in Sotera Health by 30.8% in the 4th quarter. Two Seas Capital LP now owns 4,412,106 shares of the company’s stock valued at $77,830,000 after acquiring an additional 1,038,878 shares during the period. Finally, State of Wyoming raised its position in Sotera Health by 63.8% during the fourth quarter. State of Wyoming now owns 78,617 shares of the company’s stock worth $1,387,000 after acquiring an additional 30,627 shares during the period. 91.03% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on SHC shares. Citigroup increased their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Piper Sandler reissued an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Barclays lowered their price objective on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Wall Street Zen cut Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Finally, Weiss Ratings cut shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, May 21st. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $20.29.

Sotera Health Trading Up 4.2%

SHC opened at $16.53 on Wednesday. Sotera Health Company has a 52 week low of $10.80 and a 52 week high of $19.85. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The business has a fifty day simple moving average of $15.48 and a 200-day simple moving average of $16.38. The firm has a market cap of $4.71 billion, a P/E ratio of 40.32 and a beta of 1.79.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The firm had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. During the same quarter in the prior year, the company earned $0.14 EPS. Sotera Health’s revenue was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities analysts expect that Sotera Health Company will post 0.86 earnings per share for the current year.

Insider Activity at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 15.36% of the company’s stock.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.